Hemispherx Biopharma, Inc. CEO Interviewed on CEOLIVE.TV

0 Comments 1 view(s)

PHILADELPHIA, Nov. 15, 2017 (GLOBE NEWSWIRE) — Hemispherx Biopharma, Inc. (NYSE:HEB), based in Philadelphia, focused on pharmaceuticals, today announced that Thomas K. Equels, M.S. J.D., Chief Executive Officer, was interviewed on CEOLIVE.TV on November 13, 2017.

The interview can be viewed at:

http://ceolive.tv/hemispherx-heb-ramping-up-manufacturing-to-pursue-multi-billion-dollar-immuno-oncology-market/

About CEOLIVE.TV
CEOLIVE.TV is an online investor media and news resource featuring interviews and commentary with top executives from U.S. publicly traded companies.

About Hemispherx Biopharma, Inc.
Hemispherx Biopharma, Inc. is an advanced specialty pharmaceutical company engaged in the clinical development of new drug entities …

Full story available on Benzinga.com